Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech Medical Study

Xylitol Linked to Higher Heart Attack Risk

Analysis based on 50 articles · First reported Aug 26, 2026 · Last updated Sep 08, 2026

Sentiment
-30
Attention
4
Articles
50
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The study could dampen consumer demand for xylitol-containing products, potentially affecting manufacturers of sugar-free gum, mints, toothpaste, and low-calorie foods. Regulatory scrutiny may increase, and companies may need to reformulate products or face reputational and legal risks.

Food and Beverage Pharmaceutical Healthcare

A large observational study presented at the European Society of Endocrinology Congress 2026 in Munich found that higher blood levels of the sugar substitute xylitol are associated with an increased risk of major cardiovascular events, including heart attack, stroke, and death. The study analyzed data from 17,710 participants in the Canadian Longitudinal Study on Aging and the European Prospective Investigation into Cancer (EPIC-Norfolk). In the Canadian cohort, those with the highest xylitol levels had a 57% higher risk over six years; in the European cohort, the risk was 18% higher over 30 years. The association was dose-dependent and persisted after adjusting for cardiovascular risk factors. The research, led by Dr. Marco Witkowski of Charité University Hospital in Berlin, builds on earlier work by Cleveland Clinic researchers including Dr. Stanley Hazen, which showed xylitol can enhance platelet clotting. The study is observational and does not prove causation, but researchers and the European Society of Endocrinology emphasize the need for further investigation into the cardiovascular safety of xylitol, especially as its use in consumer products grows. The FDA has also warned that xylitol is dangerous to dogs.

90 Marco Witkowski presented findings
70 Stanley Hazen published research
60 Cleveland Clinic led research
56 British Heart Foundation supported findings
40 Dan Atar commented on study
30 Dell Stanford commented on study
30 Seema Malhotra commented on study
20 Kirsty Thomas commented on study
10 Newsweek reported study
ngo
The European Society of Endocrinology hosted the congress where the study was presented and issued commentary, reinforcing its role as a key scientific body in cardiovascular research.
Importance 70.0 Sentiment 10.0
per
Dr. Marco Witkowski is the lead presenter of the study, raising his profile in cardiovascular research and potentially influencing future research directions.
Importance 70.0 Sentiment 10.0
priv
Cleveland Clinic conducted earlier research on xylitol and cardiovascular risk, providing foundational evidence that this study builds upon.
Importance 50.0 Sentiment 10.0
per
Dr. Stanley Hazen led earlier Cleveland Clinic research linking xylitol to cardiovascular events, contributing to the scientific background of the current findings.
Importance 50.0 Sentiment 10.0
cnt
The United Kingdom is the location of the EPIC-Norfolk cohort. The findings may affect UK dietary guidelines and consumer trust in xylitol-containing products.
Importance 40.0 Sentiment -10.0
govactor
The FDA has previously warned about xylitol's danger to dogs, and this study may prompt the agency to review the sweetener's cardiovascular safety in humans.
Importance 40.0 Sentiment -10.0
per
Professor Dan Atar, a member of the ESC Communication Committee, commented on the study, emphasizing the need for further research and adding institutional weight to the findings.
Importance 40.0 Sentiment 5.0
per
Dell Stanford, a senior dietitian at the British Heart Foundation, provided commentary on the study, advising caution and balanced diet. Her comments reinforce the foundation's public health messaging.
Importance 30.0 Sentiment 0.0
ngo
The British Heart Foundation is mentioned through its dietitian's comments, aligning with its mission to promote heart health. The study may support its advocacy for reducing processed food intake.
Importance 30.0 Sentiment 0.0
per
Seema Malhotra, a cardiologist, commented on the study, advising patients to avoid artificial sweeteners. His public stance may influence patient behavior and his own practice.
Importance 30.0 Sentiment 0.0
cnt
Canada is the source of one of the study cohorts (CLSA), and the findings may influence Canadian public health recommendations and consumer behavior.
Importance 30.0 Sentiment -10.0
cnt
Germany is the location of the ESC Congress and the home of lead researcher Charité, and the findings may affect German consumers and regulatory bodies.
Importance 30.0 Sentiment -10.0
per
Kirsty Thomas, a nutritionist, provided a balanced perspective, recommending interpretation within broader evidence. Her comments reflect her professional role at Prowise Healthcare.
Importance 20.0 Sentiment 0.0
priv
Prowise Healthcare is the employer of Kirsty Thomas. The company is indirectly associated with the study through her comments, but no direct impact is expected.
Importance 10.0 Sentiment 0.0
govactor
The United States — National Institutes of Health is referenced as a source for defining xylitol. It is not directly involved in the study, so impact is minimal.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.